MARKETS
S&P 5007,756.2+0.57%
NASDAQ 10029,719.9+1.08%
XBI156.40+1.62%
IBB189.75+0.94%
DOW 3054,022.3+0.31%
FTSE 10010,901.0+0.17%
Biotechnology Daily

Investors Buy Shares of Amazon.com (AMZN) on Weakness

Investors purchased shares of Amazon.com, Inc.(NASDAQ:AMZN) on weakness during trading on Thursday. $1,262.28 million flowed into the stock on the tick-up and $1,025.88 million flowed out of the stock on the…

Editor 3 min read
Investors Buy Shares of Amazon.com (AMZN) on Weakness
Investors Buy Shares of Amazon.com (AMZN) on Weakness

From the Biotech Insider archive. This article dates from Mar 17, 2019 and is preserved as first published.

Investors purchased shares of Amazon.com, Inc.(NASDAQ:AMZN) on weakness during trading on Thursday. $1,262.28 million flowed into the stock on the tick-up and $1,025.88 million flowed out of the stock on the tick-down, for a money net flow of $236.40 million into the stock. Of all equities tracked, Amazon.com had the 4th highest net in-flow for the day. Amazon.com traded down ($4.59) for the day and closed at $1,686.22

Several equities analysts recently weighed in on the stock. Wells Fargo & Co reaffirmed a “buy” rating and set a $2,100.00 target price on shares of Amazon.com in a research note on Monday, December 3rd. Nomura reaffirmed a “buy” rating on shares of Amazon.com in a research note on Tuesday, December 4th. Barclays reaffirmed a “buy” rating on shares of Amazon.com in a research note on Tuesday, December 4th. Guggenheim reaffirmed a “buy” rating and set a $2,000.00 target price on shares of Amazon.com in a research note on Thursday, January 31st. Finally, JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Amazon.com in a research note on Friday, February 1st. Five analysts have rated the stock with a hold rating and forty-three have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $2,118.63.

The company has a current ratio of 1.10, a quick ratio of 0.85 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $841.12 billion, a P/E ratio of 85.02, a PEG ratio of 2.33 and a beta of 1.62.

Amazon.com (NASDAQ:AMZN) last released its quarterly earnings results on Thursday, January 31st. The e-commerce giant reported $6.04 EPS for the quarter, topping analysts’ consensus estimates of $5.55 by $0.49. Amazon.com had a net margin of 4.33% and a return on equity of 27.02%. The firm had revenue of $72.38 billion during the quarter, compared to analysts’ expectations of $71.73 billion. During the same period in the previous year, the company earned $2.16 EPS. As a group, analysts predict that Amazon.com, Inc. will post 26.72 EPS for the current year.

com (NASDAQ:AMZN) last released its quarterly earnings results on Thursday, January 31st.

In other news, CEO Jeffrey A. Wilke sold 1,645 shares of the business’s stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $1,614.65, for a total value of $2,656,099.25. Following the completion of the sale, the chief executive officer now owns 10,000 shares in the company, valued at approximately $16,146,500. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Patricia Q. Stonesifer sold 1,375 shares of the business’s stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $1,602.00, for a total transaction of $2,202,750.00. Following the completion of the sale, the director now owns 7,861 shares of the company’s stock, valued at approximately $12,593,322. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,075 shares of company stock valued at $8,180,428. 16.30% of the stock is owned by corporate insiders.

Large investors have recently bought and sold shares of the company. Landaas & Co. WI ADV bought a new position in shares of Amazon.com during the 2nd quarter worth approximately $224,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Amazon.com by 3.0% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 54,608 shares of the e-commerce giant’s stock worth $109,373,000 after acquiring an additional 1,599 shares in the last quarter. Ironwood Investment Counsel LLC raised its stake in shares of Amazon.com by 39.7% during the 3rd quarter. Ironwood Investment Counsel LLC now owns 535 shares of the e-commerce giant’s stock worth $1,071,000 after acquiring an additional 152 shares in the last quarter. Spirit of America Management Corp NY bought a new position in shares of Amazon.com during the 3rd quarter worth approximately $110,000. Finally, Cookson Peirce & Co. Inc. bought a new position in shares of Amazon.com during the 3rd quarter worth approximately $252,000. Institutional investors and hedge funds own 55.22% of the company’s stock.

About Amazon.com (NASDAQ:AMZN)

Amazon.com, Inc engages in the retail sale of consumer products and subscriptions in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS) segments. It sells merchandise and content purchased for resale from third-party sellers through physical stores and online stores.

Filed under Biotechnology Daily

More on Biotechnology Daily

See all →